2173 related articles for article (PubMed ID: 24614609)
21. Thrombophilia in sickle cell disease: the red cell connection.
Setty BN; Rao AK; Stuart MJ
Blood; 2001 Dec; 98(12):3228-33. PubMed ID: 11719358
[TBL] [Abstract][Full Text] [Related]
22. Absence of paradoxical thrombin activation by fibrin-specific thrombolytics in acute myocardial infarction: comparison of single-bolus tenecteplase and front-loaded alteplase.
Szabo S; Letsch R; Ehlers R; Walter T; Kazmaier S; Helber U; Hoffmeister HM
Thromb Res; 2002 Apr; 106(2):113-9. PubMed ID: 12182909
[TBL] [Abstract][Full Text] [Related]
23. Anti-heparin/PF4 complexes by ELISA in patients with disseminated intravascular coagulation.
Matsuo T; Matsuo M; Sugimoto T; Wanaka K
Pathophysiol Haemost Thromb; 2007; 36(6):305-10. PubMed ID: 20224256
[TBL] [Abstract][Full Text] [Related]
24. Elevated levels of prothrombin fragment 1 + 2 indicate high risk of thrombosis.
Ota S; Wada H; Abe Y; Yamada E; Sakaguchi A; Nishioka J; Hatada T; Ishikura K; Yamada N; Sudo A; Uchida A; Nobori T
Clin Appl Thromb Hemost; 2008 Jul; 14(3):279-85. PubMed ID: 18160575
[TBL] [Abstract][Full Text] [Related]
25. [Plasma levels of antithrombin III, thrombin-antithrombin III complex, alpha 2 plasmin inhibitor and plasmin alpha 2 plasmin inhibitor complex in normal and sick newborn infants].
Shiiki M; Ariyoshi N; Nakamura T; Shirahata A
Rinsho Ketsueki; 1991 Jul; 32(7):758-65. PubMed ID: 1833569
[TBL] [Abstract][Full Text] [Related]
26. Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study.
Morange PE; Bickel C; Nicaud V; Schnabel R; Rupprecht HJ; Peetz D; Lackner KJ; Cambien F; Blankenberg S; Tiret L;
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2793-9. PubMed ID: 17023678
[TBL] [Abstract][Full Text] [Related]
27. Hemostatic Changes During Extracorporeal Membrane Oxygenation: A Prospective Randomized Clinical Trial Comparing Three Different Extracorporeal Membrane Oxygenation Systems.
Malfertheiner MV; Philipp A; Lubnow M; Zeman F; Enger TB; Bein T; Lunz D; Schmid C; Müller T; Lehle K
Crit Care Med; 2016 Apr; 44(4):747-54. PubMed ID: 26646464
[TBL] [Abstract][Full Text] [Related]
28. Centrifugal and roller pumps--are there differences in coagulation and fibrinolysis during and after cardiopulmonary bypass?
Steinbrueckner BE; Steigerwald U; Keller F; Neukam K; Elert O; Babin-Ebell J
Heart Vessels; 1995; 10(1):46-53. PubMed ID: 7730247
[TBL] [Abstract][Full Text] [Related]
29. Alterations of haemostatic markers in various subtypes and phases of stroke.
Yamazaki M; Uchiyama S; Maruyama S
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):707-12. PubMed ID: 7507362
[TBL] [Abstract][Full Text] [Related]
30. [New useful parameters or makers in diagnosis and condition. Analysis of disseminated intravascular coagulation--mainly molecular markers].
Koike K; Fujimaki M
Nihon Rinsho; 1993 Jan; 51(1):37-42. PubMed ID: 8433526
[TBL] [Abstract][Full Text] [Related]
31. Autotransfusion in coronary artery bypass grafting: disparity in laboratory tests and clinical performance.
Flom-Halvorsen HI; Ovrum E; Tangen G; Brosstad F; Ringdal MA; Oystese R
J Thorac Cardiovasc Surg; 1999 Oct; 118(4):610-7. PubMed ID: 10504624
[TBL] [Abstract][Full Text] [Related]
32. Morning hypercoagulability and hypofibrinolysis. Diurnal variations in circulating activated factor VII, prothrombin fragment F1+2, and plasmin-plasmin inhibitor complex.
Kapiotis S; Jilma B; Quehenberger P; Ruzicka K; Handler S; Speiser W
Circulation; 1997 Jul; 96(1):19-21. PubMed ID: 9236409
[TBL] [Abstract][Full Text] [Related]
33. Haemostasis alterations in coronary artery bypass grafting: comparison between the off-pump technique and a closed coated cardiopulmonary bypass system.
Scrascia G; Rotunno C; Guida P; Conte M; Amorese L; Margari V; Schinosa Lde L; Paparella D
Interact Cardiovasc Thorac Surg; 2013 May; 16(5):636-42. PubMed ID: 23335652
[TBL] [Abstract][Full Text] [Related]
34. [A coagulation of fibrinolytic study in children with nephrotic syndrome: evaluation of hypercoagulability by measuring with plasmin- alpha 2 plasmin inhibitor complex and FDP D-dimer].
Oikawa T; Muramatsu Y; Akashi S; Usui N
Nihon Jinzo Gakkai Shi; 1997 Mar; 39(2):144-9. PubMed ID: 9134831
[TBL] [Abstract][Full Text] [Related]
35. Activation markers of coagulation and fibrinolysis in twins: heritability of the prethrombotic state.
Ariëns RA; de Lange M; Snieder H; Boothby M; Spector TD; Grant PJ
Lancet; 2002 Feb; 359(9307):667-71. PubMed ID: 11879863
[TBL] [Abstract][Full Text] [Related]
36. Activation products of the haemostatic system in coronary, cerebrovascular and peripheral arterial disease.
van der Bom JG; Bots ML; Haverkate F; Meijer P; Hofman A; Kluft C; Grobbee DE
Thromb Haemost; 2001 Feb; 85(2):234-9. PubMed ID: 11246539
[TBL] [Abstract][Full Text] [Related]
37. Thrombin production, inactivation and expression during open heart surgery measured by assays for activation fragments including a new ELISA for prothrombin fragment F1 + 2.
Boisclair MD; Lane DA; Philippou H; Sheikh S; Hunt B
Thromb Haemost; 1993 Aug; 70(2):253-8. PubMed ID: 8236130
[TBL] [Abstract][Full Text] [Related]
38. Plasma thrombin-antithrombin complex, prothrombin fragments 1 and 2, and D-dimer levels are elevated after endovascular but not open repair of infrarenal abdominal aortic aneurysm.
Bailey MA; Griffin KJ; Sohrabi S; Whalley DJ; Johnson AB; Baxter PD; Ariëns RA; Scott DJ
J Vasc Surg; 2013 Jun; 57(6):1512-8. PubMed ID: 23490299
[TBL] [Abstract][Full Text] [Related]
39. [Coagulation and fibrinolysis parameters in disseminated intravascular coagulation (DIC)].
Nakagawa T; Saito H; Watanabe Y; Sato M; Murakawa E
Rinsho Byori; 1991 Mar; 39(3):309-14. PubMed ID: 1828842
[TBL] [Abstract][Full Text] [Related]
40. Activation of thrombosis and fibrinolysis following brain infarction.
Kataoka S; Hirose G; Hori A; Shirakawa T; Saigan T
J Neurol Sci; 2000 Dec; 181(1-2):82-8. PubMed ID: 11099716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
